MD Anderson Madrid opens its new Multidisciplinary Retroperitoneal Sarcoma Unit Published on 12/12/2023 The average annual incidence of soft tissue sarcomas is between 3-4 cases per 100,000 population. 15% occur in the retroperitoneum1
The ‘healthcare limbo’ of sarcoma patients Published on 12/07/2023 The rare nature of this type of cancer has resulted in a scarcity of research and, as a consequence, less consistent diagnostic and treatment criteria, along with the difficulty of accessing specific drugs
A multidisciplinary approach is key to the treatment of the more than one hundred types of sarcomas we deal with Published on 01/03/2022 All medical specialties may be involved in this disease, among the most common are Traumatology, Medical Oncology, Radiotherapy Oncology, Anatomic and Molecular Pathology, Radiodiagnosis, Rehabilitation and Plastic Surgery.
Patients with sarcoma 'play' their best or worst prognosis in the first operation Published on 10/02/2020 22% of people diagnosed with cancer in Spain have a rare tumour, according to data from the Spanish Orphan and Infrequent Tumours Group (GETHI). In these cases, as with other rare diseases, the main problems are delayed diagnosis, reduced availability of therapeutic options and, above all, the difficulty of finding professionals who are experts in a disease that only affects a small part of the population.
Dr. Ricardo Cubedo, new head of Sarcomas and Hereditary Cancer at MD Anderson Cancer Center Madrid Published on 16/07/2019 Dr. Cubedo is a member of the Spanish Breast Cancer Research Group (GEICAM) and Sarcomas (GEIS), as well as a designated expert with the European Medicines Agency (EMA), among other leading positions